Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

NCT00534794 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Elestat
DRUG: Pataday

Sponsor

Merck Sharp & Dohme LLC